Development of molecular biomarker for colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Primary outcome(s): predictability of prognosis. predictability of chemo sensitivity.
应用场景：
创建时间：
2009-06-15
相关数据集
Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma
The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better p
Figshare2017-08-11 更新180
Additional file 2 of Developing a multiomics data-based mathematical model to predict colorectal cancer recurrence and metastasis
Supplementary Material 2: Additional file 2– Supplementary Table S1: The detailed results of feature selection (the p values) are listed in Supplementary Table S1
NIAID Data Ecosystem80
DataSheet_1_A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma.pdf
ObjectivesThe study aims to analyze the expression of N6-methyladenosine (m6A)-modified genes in rectum adenocarcinoma (READ) and identify reliable prognostic biomarkers to predict the prognosis of RE
NIAID Data Ecosystem60
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
Detecting circulating tumor cells from I-IV stage colorectal cancer patients pre-and post-operatively. Analyzing the morphology and biomarkers of CTCs and builting prognosis predicting model based on
NIAID Data Ecosystem80
Ribosomal Protein S27-Like in Colorectal Cancer: A Candidate for Predicting Prognoses
Background The development and progression of colorectal cancer (CRC) involve a complex process of multiple genetic changes. Tumor suppressor p53 is capable of determining the fate of CRC cells. Howev
NIAID Data Ecosystem80
